422 related articles for article (PubMed ID: 15365366)
1. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
2. Melan-a-positive "pseudomelanocytic nests": a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin.
Beltraminelli H; Shabrawi-Caelen LE; Kerl H; Cerroni L
Am J Dermatopathol; 2009 May; 31(3):305-8. PubMed ID: 19384076
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A.
Helm K; Findeis-Hosey J
J Cutan Pathol; 2008 Oct; 35(10):931-4. PubMed ID: 18494818
[TBL] [Abstract][Full Text] [Related]
4. A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin.
Muzumdar S; Argraves M; Kristjansson A; Ferenczi K; Dadras SS
J Cutan Pathol; 2018 Apr; 45(4):263-268. PubMed ID: 29377259
[TBL] [Abstract][Full Text] [Related]
5. Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ.
Kim J; Taube JM; McCalmont TH; Glusac EJ
J Cutan Pathol; 2011 Oct; 38(10):775-9. PubMed ID: 21797920
[TBL] [Abstract][Full Text] [Related]
6. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
7. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
Busam KJ; Granter SR; Iversen K; Jungbluth AA
Am J Dermatopathol; 2000 Jun; 22(3):237-41. PubMed ID: 10871066
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
Orchard GE
Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
[TBL] [Abstract][Full Text] [Related]
10. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
11. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
Lohmann CM; Iversen K; Jungbluth AA; Berwick M; Busam KJ
Am J Surg Pathol; 2002 Oct; 26(10):1351-7. PubMed ID: 12360050
[TBL] [Abstract][Full Text] [Related]
12. S100A protein expression in the distinction between lentigo maligna and pigmented actinic keratosis.
Ribé A; McNutt NS
Am J Dermatopathol; 2003 Apr; 25(2):93-9. PubMed ID: 12652189
[TBL] [Abstract][Full Text] [Related]
13. Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease.
Mai KT; Alhalouly T; Landry D; Stinson WA; Perkins DG; Yazdi HM
Histopathology; 2002 Oct; 41(4):331-6. PubMed ID: 12383215
[TBL] [Abstract][Full Text] [Related]
14. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
[TBL] [Abstract][Full Text] [Related]
15. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
Zubovits J; Buzney E; Yu L; Duncan LM
Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
[TBL] [Abstract][Full Text] [Related]
17. Can Melan-A replace S-100 and HMB-45 in the evaluation of sentinel lymph nodes from patients with malignant melanoma?
Kucher C; Zhang PJ; Acs G; Roberts S; Xu X
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):324-7. PubMed ID: 16932024
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
Clarkson KS; Sturdgess IC; Molyneux AJ
J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
[TBL] [Abstract][Full Text] [Related]
19. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
20. Expression of Melan-A in Spitz, pigmented spindle cell nevi, and congenital nevi: comparative immunohistochemical study.
Evans MJ; Sanders DS; Grant JH; Blessing K
Pediatr Dev Pathol; 2000; 3(1):36-9. PubMed ID: 10644168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]